Updated: January 25, 2026
What Is Cibinqo? Uses, Dosage, and What You Need to Know in 2026
Author
Peter Daggett

Overview
Cibinqo (abrocitinib) is an oral JAK1 inhibitor for moderate-to-severe atopic dermatitis. Learn what it treats, how it's dosed, and what you need to know before starting it.
Is Cibinqo in stock near you?
Medfinder checks real pharmacy inventory — start a search and we'll find Cibinqo near you.
If you or someone you care for has been prescribed Cibinqo, or if you're researching treatment options for moderate-to-severe atopic dermatitis, this guide will give you a clear and complete overview of what Cibinqo is, what it treats, how to take it, and what to expect.
What Is Cibinqo?
Cibinqo is the brand name for abrocitinib, an oral prescription medication manufactured by Pfizer. It belongs to a class of drugs called Janus kinase (JAK) inhibitors — specifically, it's a selective JAK1 inhibitor. Cibinqo was first approved by the FDA on January 14, 2022, making it one of the newer oral treatment options for atopic dermatitis (eczema) in the United States.
Unlike biologics (injected medications), Cibinqo is taken as a pill once daily, which many patients prefer. It works from inside cells to block inflammatory signals that drive atopic dermatitis symptoms.
Check live stock now.
What Is Cibinqo Used For?
Cibinqo is FDA-approved for:
Refractory, moderate-to-severe atopic dermatitis (eczema) in adults and adolescents 12 years of age and older
Whose disease is not adequately controlled with other systemic drug products, including biologics like Dupixent (dupilumab)
Or when use of those therapies is inadvisable for medical reasons
This means Cibinqo is not a first-line treatment — it's specifically indicated for patients with significant, hard-to-control eczema who have not responded well enough to earlier treatments. Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by dry, inflamed, itchy skin that significantly impacts quality of life, sleep, and mental health.
Cibinqo Dosage: How Much Should You Take?
Cibinqo comes in three tablet strengths:
100 mg once daily — the recommended starting dose for most patients
200 mg once daily — recommended if an adequate response is not achieved after 12 weeks on 100 mg
50 mg once daily — for patients with moderate renal impairment (eGFR 30–59 mL/min), certain CYP2C19 drug interactions, or those known to be CYP2C19 poor metabolizers
Cibinqo should be taken at the same time each day. It can be taken with or without food, though taking it with food may reduce nausea. Do not crush or split the tablets.
Who Should Not Take Cibinqo?
Cibinqo is not appropriate for everyone. You should NOT take Cibinqo if:
You are taking antiplatelet medications (like clopidogrel or high-dose aspirin >81 mg) during the first 3 months — this is a contraindication
You have an active serious infection
You have severe renal impairment (eGFR <29 mL/min) or are on dialysis
You have severe hepatic impairment (Child Pugh C)
You are pregnant or planning to become pregnant (Cibinqo may impair fertility and harm a developing fetus)
You are under 12 years old or weigh less than 25 kg (safety not established)
What Results Can You Expect From Cibinqo?
In Phase 3 clinical trials (JADE MONO-1 and JADE MONO-2), at 12 weeks:
~47.5% of patients on 200 mg achieved IGA 0/1 (clear or almost clear skin)
~32% of patients on 100 mg achieved IGA 0/1
Significant rapid improvement in itch was observed within 2 weeks of starting treatment
Improvements in quality of life, depression and anxiety severity scores, and fatigue were also reported
Is Cibinqo a Biologic? Is It a Controlled Substance?
Cibinqo is NOT a biologic. Biologics are medications made from living organisms. Cibinqo is a synthetic small molecule — a chemically manufactured compound that's taken orally. This is why it comes as a pill rather than an injection.
Cibinqo is also NOT a controlled substance. It does not require any special prescription monitoring, DEA scheduling, or REMS program. Any licensed prescriber can write a Cibinqo prescription.
Found
Rate
on average
What Pre-Treatment Steps Are Required?
Before starting Cibinqo, your doctor will order:
TB screening (tuberculosis test — IGRA or TST)
Viral hepatitis (HBV and HCV) screening
Complete blood count (CBC) including platelet count
Lipid panel (cholesterol levels)
Renal function (eGFR) to determine correct dose
Ready to Find Cibinqo?
Once you have your prescription, finding a pharmacy that carries Cibinqo is the next step. medfinder calls pharmacies near you to check which ones have Cibinqo in stock and texts you the results — no hold music, no runaround.
Curious about exactly how Cibinqo works? Read our in-depth explainer on Cibinqo's mechanism of action.
Frequently Asked Questions
Cibinqo (abrocitinib) is FDA-approved for treating refractory, moderate-to-severe atopic dermatitis (eczema) in adults and adolescents 12 years and older. It's specifically for patients whose disease is not adequately controlled with other systemic therapies including biologics, or when those therapies are inadvisable.
The recommended starting dose of Cibinqo is 100 mg once daily. If an adequate response is not achieved after 12 weeks, your doctor may increase the dose to 200 mg once daily. A 50 mg dose is used for patients with moderate renal impairment, certain drug interactions, or CYP2C19 poor metabolizers.
Many patients begin to notice improvement in itching within 2 weeks of starting Cibinqo. More substantial skin clearance is typically evaluated at 12 weeks, which is the primary endpoint timepoint used in Phase 3 clinical trials. Clinical trials showed that about 40–50% of patients on 200 mg achieved clear or almost clear skin by 12 weeks.
Cibinqo is FDA-approved for adolescents 12 years and older who weigh at least 25 kg (about 55 pounds). It is not approved or recommended for children under 12 years of age. For younger children with atopic dermatitis, other treatments such as Dupixent (approved for ages 6 months and older) may be more appropriate.
Yes. Cibinqo can be taken with or without food. Clinical pharmacology studies show no clinically relevant effect of a high-fat, high-calorie meal on Cibinqo's absorption. Taking it with food may help reduce nausea, which is one of the more common early side effects.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Cibinqo also looked for:
More about Cibinqo
37,512 have already found their meds with Medfinder.
Start your search today.
Your information is private and never shared.





